Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1917-1925

  Ignatovica, Vita ^a   Latkovskis, Gustavs ^b,d   Peculis, Raitis ^a   Megnis, Kaspars ^a   Schioth, Helgi B ^c   Vaivade, Iveta ^a   Fridmanis, Davids ^a   Pirags, Valdis ^b,d   Erglis, Andrejs ^b,d   Klovins, Janis ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

^c UPPSALA UNIVERSITY   (Sweden)

^d PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Genetic association; Heart diseases; Myocardial infarction; Purinergic receptor

Indexed keywords

PURINERGIC P2Y1 RECEPTOR; P2RY1 PROTEIN, HUMAN;

ADULT; ALLELE; ANGINA PECTORIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LATVIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; P2RY1 GENE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; AGE; AGED; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MASS SPECTROMETRY; MIDDLE AGED; RISK FACTOR;

ANGINA;

ADULT; AGE FACTORS; AGED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LATVIA; LINKAGE DISEQUILIBRIUM; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2Y1; RISK FACTORS; THROMBOEMBOLISM;

EID: 84455160630     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0938-4     Document Type: Article

References (44)

1. Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP (1996) Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun 218(3):783-788. doi:10.1016/j.tips.2006.01.005 (Pubitemid 26050740)
2. Janssens R, Communi D, Pirotton S, Samson M, Parmentier M, Boeynaems JM (1996) Cloning and tissue distribution of the human P2Y1 receptor. Biochem Biophys Res Commun 221(3): 588-593 (Pubitemid 26153908)
3. Leon C, Vial C, Cazenave JP, Gachet C (1996) Cloning and sequencing of a human cDNA encoding endothelial P2Y1 puri-noceptor. Gene 171(2):295-297. doi:10.1016/0378-1119(96) 00027-3 (Pubitemid 26174298)
4. Moore DJ, Chambers JK, Wahlin JP, Tan KB, Moore GB, Jenkins O, Emson PC, Murdock PR (2001) Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcrip-tion-polymerase chain reaction study. Biochim Biophys Acta 1521(1-3):107-119 (Pubitemid 33020772)
5. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104(12): 1731-1737. doi:10.1172/JCI8399 (Pubitemid 30053190)
6. Malin SA, Molliver DC (2010) Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol Pain 6:21. doi:10.1186/1744-8069-6-21
7. Reiser G (1995) Ca(2?)- and nitric oxide-dependent stimulation of cyclic GMP synthesis in neuronal cell line induced by P2-purinergic/pyrimidinergic receptor. J Neurochem 64(1):61-68
8. Ryten M, Yang SY, Dunn PM, Goldspink G, Burnstock G (2004) Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures. FASEB J 18(12):1404-1406. doi:10.1096/fj.03-1175 fje03-1175fje (Pubitemid 39561595)
9. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Rama-krishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817):202-207. doi:10.1038/35051599 (Pubitemid 32144286)
10. Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84(2):289-297. doi:10.1016/S0092-8674 (00)80983-6 (Pubitemid 26040846)
11. Mills DC, Robb IA, Roberts GC (1968) The release of nucleo-tides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol 195(3):715-729
12. Park HS, Hourani SM (1999) Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets. Br J Pharmacol 127(6):1359-1366. doi:10.1038/sj.bjp. 0702690 (Pubitemid 29358936)
13. Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277-300. doi:10.1146/annurev. pharmtox.46.120604.141207 (Pubitemid 43271191)
14. Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U (1990) Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem 265(6):3088-3093
15. Gurbel PA, O'Connor CM, Cummings CC, Serebruany VL (1999) Clopidogrel: the future choice for preventing platelet activation during coronary stenting? Pharmacol Res 40(2):107-111. doi:10.1006/phrs.1999.0478S1043-6618(99)904 78-4 (Pubitemid 29378089)
16. Jauhar R, Bergman G, Savino S, Deutsch E, Shaknovich A, Parikh M, Sanborn TA (1999) Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting. Am J Cardiol 84(6):726-728, A8 (Pubitemid 29417966)
17. Azarpira N, Namazi S, Khalili A, Tabesh M (2010) The investigation of allele and genotype frequencies of CYP3A5 (1*/3*) and P2Y12 (T744C) in Iran. Mol Biol Rep. doi:10.1007/s11033-010-0628-7
18. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108(8):989-995. doi: 10.1161/01.CIR.0000085073.69189.8801.CIR.0000085073. 69189.88 (Pubitemid 37048230)
19. Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study. Circulation 108(24): 2971-2973. doi:10.1161/01.CIR. 0000106904.80795.35 (Pubitemid 37553564)
20. Rudez G, Pons D, Leebeek F, Monraats P, Schrevel M, Zwin-derman A, de Winter R, Tio R, Doevendans P, Jukema W, de Maat M (2008) Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions. Hum Mutat 29(3):375-380. doi:10.1002/humu.20641 (Pubitemid 351364939)
21. Staritz P, Kurz K, Stoll M, Giannitsis E, Katus HA, Ivandic BT (2009) Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. Int J Cardiol 133(3):341-345. doi:10.1016/j.ijcard.2007.12.118
22. Gachet C, Leon C, Hechler B (2006) The platelet P2 receptors in arterial thrombosis. Blood Cells Mol Dis 36(2):223-227. doi: 10.1016/j.bcmd.2005.12.024
23. Rozalski M, Nocun M, Watala C (2005) Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy. Acta Biochim Pol 52(2):411-415 (Pubitemid 41133775)
24. Hetherington SL, Singh RK, Lodwick D, Thompson JR, Goodall AH, Samani NJ (2005) Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 25(1):252-257 (Pubitemid 40054285)
25. Fontana P, Remones V, Reny JL, Aiach M, Gaussem P (2005) P2Y1 gene polymorphism and ADP-induced platelet response. J Thromb Haemost 3(10):2349-2350. doi:10.1111/j.1538-7836. 2005.01483.x (Pubitemid 41727218)
26. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS (2007) Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res 119(3):355-360. doi:10.1016/j.thromres.2006.02.006 (Pubitemid 44918095)
27. Sibbing D, von Beckerath O, Schomig A, Kastrati A, von Beckerath N (2006) P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel. J Thromb Haemost 4(4):912-914
28. Li Q, Chen BL, Ozdemir V, Ji W, Mao YM, Wang LC, Lei HP, Fan L, Zhang W, Liu J, Zhou HH (2007) Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Phar-macogenomics 8(6):577-586. doi:10.2217/14622416.8.6.577 (Pubitemid 46939583)
29. Jefferson BK, Foster JH, McCarthy JJ, Ginsburg G, Parker A, Kottke-Marchant K, Topol EJ (2005) Aspirin resistance and a single gene. Am J Cardiol 95(6):805-808 (Pubitemid 40332670)
30. Kunicki TJ, Williams SA, Nugent DJ, HarrisonP, Segal HC, Syed A, Rothwell PM (2009) Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease. Thromb Haemost 101(1):123-133
31. Kunicki TJ, Williams SA, Salomon DR, Harrison P, Crisler P, Nakagawa P, Mondala TS, Head SR, Nugent DJ (2009) Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost 7(12):2116-2122
32. Storey RF, Melissa ThorntonS, Lawrance R, Husted S, Wickens M, Emanuelsson H, Cannon CP, Heptinstall S, Armstrong M (2009) Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets 20(5):341-348
33. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Pat-erson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart AF, Birkett N (2009) Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 62(6): 597-608
34. Barrett JC (2009) Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009(10). doi:10.1101/pdb.ip71
35. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. doi:10.1093/bioinformatics/bth457bth457 (Pubitemid 40202029)
36. de Bakker PI (2009) Selection and evaluation of Tag-SNPs using Tagger and HapMap. Cold Spring Harb Protoc 2009(6). doi: 10.1101/pdb.ip67
37. Kirsten H, Dienst S, Emmrich F, Ahnert P (2006) CalcDalton: a tool for multiplex genotyping primer design for single-base extension reactions using cleavable primers. Biotechniques 40(2): 158
38. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575. doi:10.1086/519795 (Pubitemid 47330214)
39. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe
40. Ecke D, Hanck T, Tulapurkar ME, Schafer R, Kassack M, Stricker R, Reiser G (2008) Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J 409(1): 107-116
41. Chandler MP, Morgan EE, McElfresh TA, Kung TA, Rennison JH, Hoit BD, Young ME (2007) Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 293(3):H1609-H1616 (Pubitemid 47367207)
42. Ahmed W, Malik M, Saeed I, Khan AA, Sadeque A, Kaleem U, Ahmed N, Ajmal M, Azam M, Qamar R (2010) Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction. Mol Biol Rep 38(4): 2541-2548. doi:10.1007/s11033-010-0392-8
43. Bronic A, Ferencak G, Zadro R, Stavljenic-Rukavina A, Bernat R (2009) Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients. Mol Biol Rep 36(1):1-5. doi: 10.1007/s11033-007-9144-9
44. Jin B, Li Y, Ge-Shang QZ, Ni HC, Shi HM, Shen W (2010) Varied association of prothrombin G20210A polymorphism with coronary artery disease susceptibility in different ethnic groups: evidence from 15, 041 cases and 21, 507 controls. Mol Biol Rep 38(4):2371-2376. doi:10.1007/s11033-010-0370-1